Login / Signup

Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort.

Yao-Chun HsuDae Won JunCheng-Yuan PengMing-Lun YehHuy TrinhGrace Lai-Hung WongSung Eun KimChien-Hung ChenHyunwoo OhChia-Hsin LinLindsey TrinhVincent Wai-Sun WongEilleen YoonSang Bong AhnDaniel HuangYong Kyun ChoJae Yoon JeongSoung Won JeongHyoung Su KimQing XieLi LiuMar Riveiro-BarcielaPei-Chien TsaiElena Vargas AccarinoHidenori ToyodaMasaru EnomotoCarmen PredaSebastián MarcianoJoseph HoangChung-Feng HuangRitsuzo KozukaSatoshi YasudaDoina IstratescuDong-Hyun LeeJia-Ying SuYen-Tsung HuangJee Fu HuangChia-Yen DaiWan-Long ChuangMan-Fung YuenAdrian GadanoRamsey CheungSeng Gee LimMaria ButiMing-Lung YuMindie H Nguyen
Published in: Hepatology international (2022)
ETV and TDF did not differ significantly in the incidence of HBsAg seroclearance, which rarely occurred with either regimen.
Keyphrases
  • hepatitis b virus
  • acute lymphoblastic leukemia
  • randomized controlled trial
  • risk factors
  • systematic review